New patent for Astrazeneca Ab drug FARXIGA

Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Astrazeneca Ab drug FARXIGA appeared first on…


Do Patents Drive or Hinder Innovation?

Here’s a brief note in response to some of the discussions I’ve seen regarding the merit of patents. Many of the anti-patent arguments focus on things which probably never should have been patented. But few address the things which only exist because of patents. In some industries (e.g. software), patents are often seen as a […]


New patent expiration for Mallinckrodt Hosp drug INOMAX

Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent expiration for Mallinckrodt Hosp drug INOMAX …


New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs d…


Which pharmaceutical companies have the most gum dosed drugs?

This chart shows the pharmaceutical companies with the most gum dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most gum dosed drugs…
The post Which pharmaceutical companies have the most gum do…


Drug Patent Expirations for Nov 16, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. PRELAY (troglitazone) Sankyo Patent number: 5,859,037 Expiration Date: Nov 13, 2017 PRELAY (troglitazone) Sankyo Patent number: 6,011,049 Expiration Date: Nov 13, 2017 STARLIX (nateglinide) Novartis Patent […]


New patent for Novo Nordisk drug SAXENDA

Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent for Novo Nordisk drug SAXENDA appeared first on DrugPa…


New patent for Novo Nordisk drug NORDITROPIN NORDIFLEX

Annual Drug Patent Expirations for NORDITROPIN+NORDIFLEX Norditropin Nordiflex is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Novo Nordisk drug NORDITROPIN…


New patent for Novo Nordisk drug NORDITROPIN FLEXPRO

Annual Drug Patent Expirations for NORDITROPIN+FLEXPRO Norditropin Flexpro is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Novo Nordisk drug NORDITROPIN FLE…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: